USA / Opioids-Amicable settlement at $ 50bn in negotiations – sources

0
5
Facebook
Twitter
Pinterest
Linkedin
ReddIt
Tumblr
Telegram
Mix
VK
Digg
LINE


October 17 (Reuters) – Several US pharmaceutical and drug companies are proposing $ 22 billion worth of drugs and services valued at $ 28 billion to close the proceedings against them in the opioid crisis, it was reported Wednesday from two sources familiar with the discussions.

The pharmaceutical industry faces lawsuits by states or hundreds of municipalities or counties in the United States accusing them of knowingly fueling the potentially life-threatening addiction to opioids, which has led to a serious health crisis in recent years in the United States.

The three McKesson, AmerisourceBergen and Cardinal Health groups plan to pay $ 18 billion over 18 years, health giant Johnson & Johnson offers $ 4 billion, Reuters says two sources close aware of the discussions.

The Teva laboratory has proposed to provide $ 15 billion worth of drugs under the agreement, as well as multibillion distribution services, according to one source.

The agreement proposed by Teva would extend over 10 years, whose total value is estimated at about 28 billion dollars, add the two sources, without however knowing how was calculated this estimate.

Negotiations are being conducted by attorneys general in Texas, Tennessee, North Carolina and Pennsylvania, the source said, adding there was no guarantee that an agreement would be reached.

At least 400,000 people have died in the last twenty years in the United States from opioid-related overdoses sold legally or illegally, according to federal statistics. (Nate Raymond in Boston, with Bangalore editorial, Arthur Connan for French service)



Source link
https://fr.reuters.com/article/frEuroRpt/idFRL5N2720CK

Dmca

LEAVE A REPLY

Please enter your comment!
Please enter your name here

sixteen − 4 =